Worldquant Millennium Advisors LLC Alkermes Plc. Transaction History

Worldquant Millennium Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $2.23 Million - $2.78 Million	-114,369 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $1.31 Million - $2.28 Million	61,097 Added 114.69%	114,369 $2.58 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $1.51 Million - $1.94 Million	53,272 New	53,272 $1.94 Million

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.52B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.